Publications by authors named "Marco Jansen"

Claim this Profile
I
ITPK1 Sensitizes Tumor Cells to IgA-dependent Neutrophil Killing In Vivo.
Connor A Richterich, Meike E W Logtenberg, Marco J H Jansen, Mireille Toebes, Kaspar Bresser

J Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade.
Chilam Chan, Marjolein Stip, Maaike Nederend, Marco Jansen, Elsemieke Passchier

J Immunother Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models.
Marjolein C Stip, Mitchell Evers, Maaike Nederend, Chilam Chan, Karli R Reiding, Marco Jansen

J Immunother Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma.
Mitchell Evers, Marjolein Stip, Kaylee Keller, Hanneke Willemen, Maaike Nederend, Marco Jansen

J Immunother Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Induction of an Effective dsRNA-Mediated Resistance Against Tomato Spotted Wilt Virus by Exogenous Application of Double-Stranded RNA Largely Depends on the Selection of the Viral RNA Target Region.
Saeid Tabein, Marco Jansen, Emanuela Noris, Anna Maria Vaira, Daniele Marian

Front Plant Sci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The high-affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma.
Lisette Bevaart, Marco J H Jansen, Martine J van Vugt, J Sjef Verbeek, Jan G J van de Winkel

Cancer Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
Heidi H van Ojik, Lisette Bevaart, Christopher E Dahle, Annie Bakker, Marco J H Jansen

Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma.
Annemiek B van Spriel, Heidi H van Ojik, Annie Bakker, Marco J H Jansen, Jan G J van de Winkel

Blood· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis